Meta Biomed Co. Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Meta Biomed Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, Meta Biomed Co. Ltd (059210) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.05 Billion ≈ $714.42K USD) by net assets (₩121.24 Billion ≈ $82.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Meta Biomed Co. Ltd (2011–2024)

Cash flow conversion efficiency of Meta Biomed Co. Ltd from 2011 to 2024. This chart illustrates how Meta Biomed Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 059210 share price today for real-time trading data and today's change.

Meta Biomed Co. Ltd Cash Flow Conversion Ratio Explained

Meta Biomed Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Meta Biomed Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Meta Biomed Co. Ltd ranked by their cash flow conversion efficiency. Also see 059210 stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Fy Grp Ltd TW:6807	0.016x
Mofast AB ST:MOFAST	0.005x
Hankook Cosmet KO:123690	0.000x
WithTech Inc. KQ:348350	-0.043x
Techbond Group Bhd KLSE:5289	0.028x
Nahar Industrial Enterprises Limited NSE:NAHARINDUS	0.143x
Impulse Fitness Solutions SA PA:MLIFS	N/A
Choong Ang Vaccine Laboratory Co. Ltd KQ:072020	0.053x

Annual Cash Flow Conversion Efficiency for Meta Biomed Co. Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Meta Biomed Co. Ltd from 2011 to 2024. Review Meta Biomed Co. Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩93.34 Billion ≈ $63.25 Million	₩22.63 Billion ≈ $15.34 Million	0.242x	+72.44%
2023-12-31	₩72.66 Billion ≈ $49.24 Million	₩10.22 Billion ≈ $6.92 Million	0.141x	-6.98%
2022-12-31	₩60.59 Billion ≈ $41.06 Million	₩9.16 Billion ≈ $6.21 Million	0.151x	-20.83%
2021-12-31	₩58.32 Billion ≈ $39.52 Million	₩11.14 Billion ≈ $7.55 Million	0.191x	+88.43%
2020-12-31	₩47.98 Billion ≈ $32.51 Million	₩4.86 Billion ≈ $3.29 Million	0.101x	+88.40%
2019-12-31	₩53.27 Billion ≈ $36.10 Million	₩2.86 Billion ≈ $1.94 Million	0.054x	+150.87%
2018-12-31	₩49.97 Billion ≈ $33.86 Million	₩-5.28 Billion ≈ $-3.58 Million	-0.106x	-1857.36%
2017-12-31	₩46.01 Billion ≈ $31.18 Million	₩-248.51 Million ≈ $-168.41K	-0.005x	-105.54%
2016-12-31	₩51.59 Billion ≈ $34.96 Million	₩5.03 Billion ≈ $3.41 Million	0.098x	+0.59%
2015-12-31	₩50.87 Billion ≈ $34.47 Million	₩4.93 Billion ≈ $3.34 Million	0.097x	+1547.11%
2014-12-31	₩44.20 Billion ≈ $29.96 Million	₩-296.24 Million ≈ $-200.76K	-0.007x	-108.04%
2013-12-31	₩44.54 Billion ≈ $30.18 Million	₩3.71 Billion ≈ $2.52 Million	0.083x	-11.04%
2012-12-31	₩40.89 Billion ≈ $27.71 Million	₩3.83 Billion ≈ $2.60 Million	0.094x	-10.84%
2011-12-31	₩39.05 Billion ≈ $26.46 Million	₩4.10 Billion ≈ $2.78 Million	0.105x	--

About Meta Biomed Co. Ltd

KQ:059210 Korea Healthcare Equipment & Supplies

Market Cap

$56.20 Million

₩82.93 Billion KRW

Market Cap Rank

#21240 Global

#1240 in Korea

Share Price

₩3530.00

Change (1 day)

-4.08%

52-Week Range

₩3385.00 - ₩6220.00

All Time High

₩6954.44